Moreover, to potentiate anti-cancer immunity, some OVs have been genetically engineered to express different cytokines (GM-CSF, IL12, and IL15), to enhance antigen presentation, or to elicit a more effective immune response against cancer cells [839,840]. The gene discussed is IL15; the disease is cancer.